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Abstract
Background: This retrospective study aimed to investigate the diagnostic relation between the mean platelet volume
(MPV) and supraventricular tachyarrhythmia (SVT) in patient with documented atrial tachyarrhythmia in the emergency
department (ED).
Methods: Two study groups were compared; a SVT group with arrive at the ED with documented SVT (n=122) and 100
healthy adult without any palpitation symptom, arrhythmic disease, and with normal physical examination results that were
brought for checkups to the cardiology polyclinic were classified as control group. Blood samples were obtained from all
patients for determining the hematologic counts and MPV during first hour in ED period.
Results: In terms of  the focus of  the study, hemoglobin, neutrophil count, mean cell volume (MCV), red cell distribution
width (RDW), platelet, white blood cell (WBC), and lymphocyte counts were similar in both group (p>0.05). MPV in the
SVT group was significantly higher than in the control group (9.12±1.22 flvs 8.64±0.89 fl, p<0.001). Multivariate logistic
regression analysis showed that just MPV was independent predictor of SVT in patients with palpitation in ED (odds ratio
[OR] 8.497, 95% confidence interval (6.181 to 12.325), p=0.012).
Conclusions: The present study described that MPV is helpful parameter for the diagnosis of SVT in emergency department,
for the first time in the literature.
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Introduction
Palpitation is one of the most common symptoms
of patients presenting to the emergency department
(ED) and found in up to 10% of the patients who
applied to ED1. Many patients with palpitation arrive
at the ED with or without documented
supraventricular tachyarrhythmia (SVT). The
diagnosis of palpitation can be difficult in the ED
and the waiting time for a first appointment with an
arrhythmia clinic can be very long. Previous studies
have shown that inflammation is sufficient to facilitate
the initiation of  SVT, and recent evidence has
demonstrated that an elevated inflammation markers
may predict atrial tachycardia’s in some patients1-3.
The mean platelet volume (MPV) is
potentially one of the most important biomarkers
of platelet activity and calculated by automatic blood
count equipment during routine blood counts4. MPV
is a marker of platelet function and is positively
associated with indicators of  platelet activity. An
increased MPV is an indicator of larger and more
reactive platelets5. Previous studies showed that
increased mean platelet volume (MPV) is closely
correlated with inflammation and to reflect
inflammatory burden in different condition6-8. In our
knowledge, this is the first study in the literature about
the relation between SVT and MPV.
In this study, we aimed to investigate the
relation between MPV and SVT in patient with
documented atrial tachyarrhythmia in ED.
Methods
This retrospective study was approved by our
Institutional Ethics Committee of Abant Izzet Baysal
University Medical School. Patient data were obtained
from the computer record of our hospital and
analyzed. This study was performed in the ED of
Abant Izzet Baysal University, School of  Medicine
Hospital between September 2011 and December
2012.
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During the study period, 248 consecutive
patients with palpitation were treated in the ED. A
total of 126 patients were excluded from this study
due to missing information and exclusion criteria.
We included 122 patients who arrive at the ED with
documented SVT and 100 healthy adult without any
palpitation symptom, arrhythmic disease, and with
normal physical examination results that were
brought for checkups to the cardiology polyclinic
were classified as control group.
Patients were excluded by the following criteria: to
have elevated serologic markers of inflammation
independent of the association with their arrhythmia:
patients with a history of a myocardial infarction or
elevated troponin levels within the previous 3 months,
major trauma or surgery within the previous 3
months, any chronic inflammatory disease (including
chronic rheumatologic diseases requiring
immunosuppressive agents), chronic infectious
diseases requiring treatment, any active malignancy,
any acute rheumatologic or infectious disease
(including symptoms of a common upper
respiratory tract infection), or any other condition
that would be expected to cause a fever, elevated
white blood cell count, or elevated erythrocyte
sedimentation rate. Those who might have been
unable to produce elevated serologic markers were
also excluded: patients on immunosuppressive
therapy (e.g. steroids), and those with leukopenia of
any etiology. Patients with congenital heart disease
(corrected or not) were also excluded.
Age, gender, leukocyte and thrombocyte
counts at the time of hospital admission, MPV values,
and ECG were recorded. The MPV was
determined on arrival at the ED through the brachial
vein, collected into tubes containing
ethylenediaminetetraacetic acid (EDTA), and
processed within 1 hour after venipuncture. For the
measurements of  the hematologic counts and MPV,
samples were analyzed within 20 min after collection
with an automated flow counter (Beckman Coulter
LH 750, USA).
The results are presented as mean ± SD or
frequency (percentage) as appropriate. A % test or
Fisher exact test, as appropriate, was used for the
statistical analysis of  categorical variables. Continuous
variables were compared using Mann-Whitney U test.
One-way analysis of  variance (ANOVA) with Fisher
LSD comparisons was used to compare more than
two parametric variables. The variables with
univariate comparisons of p<0.05 between SVT and
control group were eligible for inclusion in an entry
selection multiple logistic regression model, which
identified the clinical factors in the ED that were
potential predictors of  SVT. To determine the
accuracy and respective best cut-off values of MPV
for predicting SVT, the receiver operating
characteristic (ROC) curves and their corresponding
areas under the curve were used. A p value of  <0.05
was considered statistically significant. A common
statistical package (SPSS 17.0 for Windows; SPSS,
Chicago, Illinois, USA) was used to perform all
statistical tests.
Result
During the 16 month period of  the study, 248
consecutive patients visited the ED due to palpitation.
Of those, 126 were excluded. Thus, 122 patients
(46 men and 76 women) were eligible for enrolment
in the final analysis. The demographic and clinical
characteristics of the study patients are depicted in
table 1. In terms of  the focus of  the study,
hemoglobin, neutrophil count, mean cell volume
(MCV), red cell distribution width (RDW), platelet,
white blood cell (WBC), and lymphocyte counts were
similar in both groups (table 1). MPV in the SVT
group was significantly higher than in the control
group (9.12±1.22 flvs 8.64±0.89 fl, p<0.001; figure
1).
In order to assess the potential independent
predictors of SVT in patients with palpitation,
multiple logistical regression analysis was performed
and included data yielding significant differences
(p<0.05) between the SVT group and the control
group individually.
After adjusting for demographic and all
hematologic factors (age, gender, smoking, body
mass index, white blood cell count, hemoglobin,
hematocrit, neutrophil count, MCV, RDW, MPV,
leucocyte count and platelet count), it was found that
just MPV showed significance in a binary logistical
regression model (odds ratio [OR] 8.497, 95%
confidence interval (6.181 to 12.325), p=0.012).
The ROC curve analysis of  MPV when
predicting SVT in patients with palpitation was
constructed and the areas under the curve was found
to be 0.583 (95% CI 0.506 to 0.660, p=0.036; figure
2). The best cut-off values for MPV when predicting
SVT in patients with palpitation presenting at the
ED were 7.95 fl (sensitivity 88.2%; specificity 32.3%)
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Table 1:  Baseline demographic characteristics and hematologic parameters of  the study population
SVT (n=126) Control (n=100) p value
Age (years) 32.9 ± 8.4 32.2 ± 8.6 0.231
Gender (male/female) 34/92 30/70 0.618
Smoking, n (%) 37 (29.3%) 22 (22.0%) 0.097
Creatinine (mg/dl) 1.01 ± 0.4 0.89 ± 0.22 0.802
Hemoglobin, g/dL 13.20 ± 1.75 13.32 ± 1.63 0.605
Hematocrite 39.45 ± 1.74 39.84 ± 4.37 0.527
MCV, fL 82.9  ± 8.6 81.8 ±8.3 0.549
RDW (%) 16.58 ± 0.68 16.54 ± 0.50 0.612
Platelet count, K/uL 239.01 ± 78.16 253.64 ± 64.03 0.527
MPV, fl 9.11 ± 1.21 8.64 ± 0.89
WBC count 7.62 ± 1.84 7.66 ± 1.90 0.901
Lymphocyte, K/uL 2.1 [1.4] 2.2 [1.2] 0.324
Neutrophil, x10 9 6.5 [1.5] 6.3 [1.5] 0.231
Data are shown as mean±SD, median [interquartile range] *Student’s t-test and Mann Whitney U test were
used. MCV, mean corpuscular volume; MPV, mean platelet volume; RDW, red cell distrubition width; WBC,
white blood cell.
Figure 1: The comparison of MPV level in two groups
Figure 2: ROC curve analysis for MPV
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Discussion
This study demonstrated that MPV was significantly
higher in patients with documented SVT in ED than
in control subject. In addition, we showed that MPV
was an independent predictor of  SVT. To the best
of our knowledge, this the first study that evaluate
the relationship between MPV and SVT in the
literature.
Platelets are blood elements with various
densities and sizes. Platelets have important
pathophysiological roles, including inflammation and
coagulation9 . Previous studies have been shown that
platelet volume, when measured as MPV, is a marker
of platelet function and is positively associated with
indicators of platelet activity 10 . In conclusion, an
increased MPV is shown more reactive platelets.
Previous studies showed that increased in MPV is
closely correlated with inflammation and to reflect
inflammatory burden in different condition6-8. MPV
is a parameter easily calculated by automatic blood
count equipment during routine blood counts in all
ED services. However, most of  time MPV is not
generally taken into consideration by physicians.
SVT’s are the most common encountered
diseases seen in emergency department. Many patients
with this symptom arrive at the ED with or without
documented SVT. The diagnosis of  SVT can be
difficult in the ED and the waiting time for a first
appointment with an arrhythmia clinic can be very
long. A detailed history, physical examination, and
electrocardiography (ECG) are of limited value in
the differential diagnosis, because most rhythm
disturbances are of a paroxysmal nature11. Despite
this approach, in many cases the etiology of
palpitation remains unclear in the ED. The literature
contains only limited data from small-scale studies
assessing the diagnostic values of biomarkers in
patients presenting to the ED with SVT 12-14. Previous
studies concluded that inflammation may play an
important role in SVT 15,16. Chung et all concluded
that an elevated inflammation markers (specially C-
reactive protein) may predict atrial tachycardia’s in
some patients. They found that CRP was elevated in
patients with lone atrial arrhythmias in the absence
of structural heart disease when compared with the
control subjects. Also, they suggested that elevated
CRP may be related to the “burden” of AF 1. Fustaci
et al. demonstrated that marked inflammatory
infiltrates in the atrial biopsies of patients with lone
AF 17 . Additionally, previous studies concluded a
decrease in inflammation after cure of atrial
arrhythmias15, 18. The results of all these previous
studies suggested that atrial tachyarrhythmia’s may
be responsible for or at least stimulate a systemic
inflammatory process. We found in our study as a
similar to previous results that MPV was significantly
higher in patients with documented SVT in ED than
in control subject. Also, this study concluded that
MPV was an independent predictor of  SVT. We
hypothesis that all of these relation can be helpful in
ED for the diagnosis of  SVT.
Limitation
The main limitation of our study was the small
sample size. A small sample size can result in a low
statistical power for equivalency testing, leading to
false-negative results.
However, establishing a study group without
comorbidities (e.g. diabetes mellitus, hypertension,
and cardiovascular or renal disorders) is difficult.
Second, because of the retrospective nature of data
collection, echocardiographic parameters were not
obtained concomitantly with blood sampling. Also,
we were unable to evaluate some factors, such as
hormone replacement therapy and some drugs,
which have been effected to the MPV, because data
on these variables were not collected.
Conclusion
The present report is the first study evaluating the
relationship between MPV and SVT in ED. In brief,
the present study described that MPV is helpful
parameter for the diagnosis of SVT in emergency
department, for the first time in the literature.
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